INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 02, 2009 |
Director
Trans History: 381
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Jan 02, 2009 |
Director
Trans History: 547
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Jan 02, 2009 |
Director
Trans History: 368
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Jan 02, 2009 |
Director
Trans History: 326
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Dec 17, 2008 |
VP, Controller and Asst. Treas
Trans History: 372
|
VP, Controller and Asst. Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Dec 17, 2008 |
SVP, Clinical Development
Trans History: 208
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Jan 02, 2008 |
Director
Trans History: 282
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Jan 02, 2008 |
Director
Trans History: 466
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Jan 02, 2008 |
Director
Trans History: 312
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Jan 02, 2008 |
Director
Trans History: 381
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.